Latest News

PureTech Health and Novartis to advance clinical-stage programmes

US-based PureTech Health has signed a licensing and equity agreement with Swiss company Novartis to advance two clinical-stage programmes targeting the mechanistic target of rapamycin complex...

PureTech Health and Novartis to advance clinical-stage programmes

Season’s Greetings

Season’s Greetings

Ab Initio and Pfizer partner to discover GPCR activating antibodies

US-based Ab Initio Biotherapeutics and Pfizer have signed a research and licence agreement to discover novel therapeutic antibodies against an undisclosed target in the G-protein coupled...

Ab Initio and Pfizer partner to discover GPCR activating antibodies

Ferring’s Rekovelle receives marketing authorisation from EC

The European Commission (EC) has granted marketing authorisation for Swiss-based Ferring Pharmaceuticals’ Rekovelle (follitropin delta), a human recombinant follicle stimulating hormone (human...

Ferring’s Rekovelle receives marketing authorisation from EC

CDC study reveals Zika virus replicates in foetal brain and placentas

A new study by the US Centers for Disease Control and Prevention (CDC) has revealed that the Zika virus replicates in the brain tissues of infants with microcephaly and persists in foetal...

CDC study reveals Zika virus replicates in foetal brain and placentas

Novartis launches new SMS for Life 2.0 healthcare programme in Nigeria

Swiss company Novartis has launched a new healthcare programme called SMS for Life 2.0 in Nigeria’s Kaduna State....

Novartis launches new SMS for Life 2.0 healthcare programme in Nigeria

UK researchers find ‘safety catch’ in cell division machinery

UK researchers find ‘safety catch’ in cell division machinery

New research identifies mechanism for genetic risk of developing myeloma

New research funded by Myeloma UK has identified the mechanism that explains how a key genetic variant acts to increase the risk of developing myeloma....

New research identifies mechanism for genetic risk of developing myeloma

Proteros and Merck sign new research agreement on epigenetic target

German biotech company Proteros biostructures has signed a second research agreement with Merck Sharp & Dohme in the US to develop small molecule compounds against an additional epigenetic...

Proteros and Merck sign new research agreement on epigenetic target

Singapore researchers artificially generate mouse blood from skin cells

Singapore researchers artificially generate mouse blood from skin cells

US FDA approves Intrarosa to treat dyspareunia

The US Food and Drug Administration (FDA) has approved Intrarosa (prasterone) to treat women experiencing moderate-to-severe pain during sexual intercourse...

US FDA approves Intrarosa to treat dyspareunia

New study finds modified virus could stimulate immune attack on liver cancer cells

New study finds modified virus could stimulate immune attack on liver cancer cells

Oxford researchers work on two EU-funded projects to deliver new antibiotic programme

University of Oxford researchers are supporting two European Union (EU) funded programmes, in a bid to deliver a novel antibiotic programme for clinical...

Oxford researchers work on two EU-funded projects to deliver new antibiotic programme

Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma Corporation

US-based biopharmaceutical company Incyte Corporation has entered a distribution agreement for the commercialisation of its drug named Iclusig (ponatinib) in Greece with GENESIS...

Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma Corporation

M&As this week: CiToxLAB, Sichuan Kelun Pharma

French-based pre-clinical services provider CiToxLAB Group has announced that it has acquired a pre-clinical contract research company known as...

M&As this week: CiToxLAB, Sichuan Kelun Pharma

Haiti launches cholera vaccination campaign

Haiti has launched an emergency cholera vaccination campaign, under which more than 800,000 affected by Hurricane Matthew last month will be...

Haiti launches cholera vaccination campaign

University of Adelaide researchers test drug that promises to prevent pre-term birth

Researchers at the University of Adelaide have conducted a successful drug test that shows early promises of preventing pre-term...

University of Adelaide researchers test drug that promises to prevent pre-term birth

Teva receives approval for generic Tribenzor in US

Teva Pharmaceutical Industries has secured approval for generic Tribenzor (olmesartan medoxomil, amlodipine and hydrochlorothiazide) tablets in the US and is in the last stages of launch preparation....

Teva receives approval for generic Tribenzor in US

MHRA grants US patients with one form of blood cancer access to investigational medicine

The Medicines Healthcare Products and Regulatory Agency (MHRA) has granted US-based patients with one form of blood cancer access to the investigational medicine, nivolumab, through the...

MHRA grants US patients with one form of blood cancer access to investigational medicine

NICE recommends treatment with 60mg of ticagrelor in post-heart attack patients

AstraZeneca has announced that National Institute of Health and Care Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending 60mg of ticagrelor with aspirin...

NICE recommends treatment with 60mg of ticagrelor in post-heart attack patients

M&As this week: Canopy Growth Corporation, Novogen, Karo Pharma

Canadian cannabis company Canopy Growth Corporation has completed the acquisition of medical cannabis company Vert...

M&As this week: Canopy Growth Corporation, Novogen, Karo Pharma
cachename:Newscachekey:rd-137342983_1031809799_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_1300192291